Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service. A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California San Francisco. Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com

Subscribe

Title Date published
2.08 Questions of the Week: the MKSAP, the USMLE Step 2 CK, & From a Med Student 2019-08-22
2.07 Translational Research & Physical Examination Pet Peeves with Dr. Adam Cifu 2019-08-16
2.06 Heart Failure, Choosing a Specialty, & the Bayesian Approach with Dr. Frank Harrell 2019-08-06
2.05 Reup! Cancer Screening 101 with Dr. Adam Obley 2019-07-31
2.04 Reup! Tumor-Treating Fields for Glioblastoma with Dr. Michael Hayes 2019-07-30
2.03 Dr. Charles Moertel and the Modern Oncologist & Cancer Screening 101 with Dr. Adam Obley 2019-07-23
2.02 BONUS! Improving Access to Prescription Drugs through Policy Change with Dr. Stacie Dusetzina 2019-07-17
2.01 Selinexor, ECHELON-2, Parachutes, Tumor-Treating Fields, & MedTwitter 2019-07-12
1.68 Voxeletor with Dr. Olson & Humanizing Cancer, Defining Cancer, and more with Dr. David Steensma 2019-07-05
1.67 MONALEESA-7 and the Cost of Cancer Drugs with Dr. Stacie Dusetzina 2019-06-27
1.66 Employing Medical Writers & Frequentist vs Bayesian Methods with Dr. Allen Pannell 2019-06-20
1.65 BONUS! Focusing and Building Your Presence on Twitter 2019-06-12
1.64 Effectiveness of Cancer Screening with Dr. Joaquín Chapa and POLO with Dr. Emerson Chen 2019-06-06
1.63 POLO, TITAN, & from ASCO: FDA Approval, Surrogate Endpoints, and Patient Experience 2019-06-04
1.62 Rates of Cancer Screening, BILCAP Outcry, Waterfall Plots and Response Rate, & Dr. Jeff Sharman 2019-05-23
1.61 Postpublication Metrics of RCTs, PCP Appointment Time, Bortezomib, & Dr. Christopher Booth 2019-05-15
1.60 I-PREDICT, Flawed Phase I Trials, & the Cost of Drugs with Dr. Daniel Hartung 2019-05-09
1.59 BONUS! Should Evidence Come with an Expiration Date? with Palmer Greene 2019-05-08
1.58 Magic Mouthwash with Dr. Arjun Gupta & Precision Oncology with Dr. Talal Hilal 2019-05-07
1.57 BONUS! Control Arm Quality in RCTs Leading to Anticancer Drug FDA Approval with Dr. Talal Hilal 2019-05-02
1234567891011121314151617181920

Comments about Plenary Session - inactive due to federal service

comments powered by Disqus
Advertisment: